These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6342746)

  • 1. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
    Lloyd RV; Sisson JC; Marangos PJ
    Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G; Wells SA; Baylin SB
    Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
    Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
    Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of multiple endocrine neoplasia (MEN), type 2A. Immunohistochemical and ultrastructural study of medullary carcinoma of the thyroid].
    Tabuse Y; Tabuse K; Kawaguchi T; Kodama E; Katsumi M; Hiraoka J; Ohno T
    Nihon Geka Hokan; 1983 Sep; 52(5):736-43. PubMed ID: 6144294
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study in thyroid cancer.
    Beltrami CA; Barbatelli G; Criante P; Paliaga A; Amadi CE
    Appl Pathol; 1987; 5(4):229-45. PubMed ID: 2446641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.
    Krisch K; Krisch I; Horvat G; Neuhold N; Ulrich W
    Histopathology; 1985 Oct; 9(10):1077-89. PubMed ID: 2417931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult medullary thyroid carcinoma. Unusual histologic variant presenting with metastatic disease.
    Aldabagh SM; Trujillo YP; Taxy JB
    Am J Clin Pathol; 1986 Feb; 85(2):247-50. PubMed ID: 3946309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyphil and squamous variants of medullary thyroid carcinoma.
    Dominguez-Malagon H; Delgado-Chavez R; Torres-Najera M; Gould E; Albores-Saavedra J
    Cancer; 1989 Mar; 63(6):1183-8. PubMed ID: 2917321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
    Sikri KL; Varndell IM; Hamid QA; Wilson BS; Kameya T; Ponder BA; Lloyd RV; Bloom SR; Polak JM
    Cancer; 1985 Nov; 56(10):2481-91. PubMed ID: 2412687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CEA determination to differentiate between pheochromocytoma with ectopic calcitonin formation and type-II multiple endocrine neoplasms].
    Cordes U; Rothmund M; Eberle S; Krause U; Kolbe K; Braun B; Reinsdorf S; Beyer J
    Dtsch Med Wochenschr; 1983 Mar; 108(12):462-4. PubMed ID: 6131802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor.
    Ruppert JM; Eggleston JC; deBustros A; Baylin SB
    Am J Surg Pathol; 1986 Jul; 10(7):513-8. PubMed ID: 2873751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.
    Adewole IF; Newlands ES
    Med Oncol Tumor Pharmacother; 1987; 4(1):11-5. PubMed ID: 3037205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of calcitonin and carcinoembryonic antigen in long-term organ culture of human medullary thyroid carcinoma: biochemical and immunocytochemical studies.
    Raue F; Boller G; Rix E; Schmidt-Gayk H; Ziegler R
    Klin Wochenschr; 1985 Mar; 63(5):205-10. PubMed ID: 3990162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a.
    Heath H; Sizemore GW; Carney JA
    J Clin Endocrinol Metab; 1976 Aug; 43(2):428-35. PubMed ID: 950371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.